
Abemaciclib is a targeted cancer therapy (CDK4/6 inhibitor) used to treat HR-positive, HER2-negative advanced or metastatic breast cancer, often in combination with hormone therapy, by slowing cancer cell growth.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Abemaciclib |
| Strength | 150mg |
| Pack size | 14 Tablets |
| Used For | Metastatic breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 Tablets | $370 | £274 | A$515 | ₱23,195 | د.ت1,077.07 | ₩495,467 | lei 1,675 | HK$2,902 | RM1,505 | ฿12,217 | S$469 | د.إ1,359.01 | ر.س1,389.35 | ر.ق1,347.17 | د.ك112.850 |
Abemaciclib is a CDK4/6 inhibitor. It blocks cyclin-dependent kinases (CDK4 and CDK6), which are proteins that help cancer cells divide. By stopping these signals, it prevents cancer cells from multiplying.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.